Helen Seers
Dr. Helen Seers, PhD, BSc, CPsychol, AFBPsS
Dr Helen Seers is Impact and Evaluation Lead at Penny Brohn UK, Co-Founder and Co-Director of Meaningful Measures Ltd and Visiting Research Fellow at UWE. She has over 20 years' experience in research, evaluation and evidence-based practice across integrative healthcare, cancer support, social prescribing and personalised care.
Helen has dedicated much of her career to strengthening the evidence base for personalised care – working with the NHS, charities, and integrative and complementary therapy practitioners. At Penny Brohn UK she leads evaluation and research service to and aims to demonstrate the impact of this charity to funders and collaborators. She has also previously established the charity's NHS Information Standard (now PIF Tick) accredited cancer information service, providing evidence-based information on complementary/ integrative therapies. Earlier in her career she contributed to the internationally recognised CAM-Cancer project.
Through Meaningful Measures, Helen supports organisations across the UK and internationally to improve health and wellbeing services using the NHS Accredited person-centred outcome measures MYCaW® and MYMOP®. These tools capture the are widely used in complementary therapy research and enable people to identify what matters most to them and measure changes in their symptoms, wellbeing and quality of life over time - supporting both individual care and service evaluation. She works collaboratively with complementary and integrative medicine organisations, and also personalised care projects in the NHS, to enable best practice when using outcome measures.
Join BSIO
By becoming a member of BSIO, you can help to support the development of integrative oncology in the UK and influence the development of the association. Be part of the movement to provide evidence-based integrative healthcare to improve the lives of people affected by cancer.